Healthcare Insights
A publication for the clients of Simon-Kucher & Partners
2021 - Volume 13, Issue 1
|
|
|
|
|
|
NICE Highly Specialized Technologies
Marc Matar, Graham Tatham, Sam Calderwood, and Shavinder Girn
The NICE Highly Specialized Technologies appraisal acts as a gatekeeper for innovative therapies in ultra-orphan indications in the UK. We review the HST appraisal process.
Read more ▹
|
|
|
|
China Medtech Industry: Trends and Recommendations
Bruce Liu, Yishu Pi, and Raf Onclin
Our recent China Medtech Market Access Trends survey provides insight into how COVID-19, changing channel dynamics, and new medical policies will shape the strategies and outlooks of industry leaders. We advise on how medtech companies can respond to these trends.
Read more ▹
|
|
|
|
|
|
|
|
|
|
Introducing Our Newest Life Sciences Partners
|
|
|
|
|
|
|
Market Access Excellence (MAXX) Scorecard:
|
|
|
|
Your Market Access and Pricing (MAP) function plays a pivotal role in a product’s success. Test your MAP with our MAXX Scorecard.
Take the Survey! ▹
|
|
|
|
|
Stay tuned for more information coming soon!
|
|
|
|
|
Our Life Sciences division operates from 20 offices worldwide. Click on the map above to learn more!
|
|
|
|
|
Simon-Kucher & Partners
Simon-Kucher & Partners is a global consulting firm with more than 1,400 professionals in 40 offices worldwide focusing on TopLine Power®. Founded in 1985, the company has more than 30 years of experience providing strategy and marketing consulting and is regarded as the world’s leading pricing advisor.
|
|
|
|
www.simon-kucher.com
|
© 2021 Simon-Kucher & Partners
Strategy & Marketing Consultants
Willy-Brandt-Allee 13, 53113 Bonn, Germany
All rights reserved.
For details on how we protect the privacy of visitors to our website, please click here.
Imprint | Data Privacy
|
|
|
|
|
|